Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Psychotropic medications in autism: practical considerations for parents.

Literature DB >> 21170674

Psychotropic medications in autism: practical considerations for parents.

Abstract

Medications are widely prescribed in children with autism spectrum disorders. Most commonly these medications are used to decrease symptoms that fall under three main clusters: irritability, ADHD-like symptoms, and repetitive behaviors. In this guide we introduce basic approaches to medications in children with autism and review the scientific evidence in each symptom cluster.

Entities: Disease Species

Mesh：

Substances：
Psychotropic Drugs

Year: 2012 PMID： 21170674 DOI： 10.1007/s10803-010-1144-2

Source DB: PubMed Journal: J Autism Dev Disord ISSN： 0162-3257

15 in total

Review 1. Treatment of aggression in children and adolescents with autism and conduct disorder.

Authors: Christopher J McDougle; Kimberly A Stigler; David J Posey
Journal: J Clin Psychiatry Date: 2003 Impact factor: 4.384

2. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Authors:
Journal: Arch Gen Psychiatry Date: 2005-11

3. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.

Authors: K M Belsito; P A Law; K S Kirk; R J Landa; A W Zimmerman
Journal: J Autism Dev Disord Date: 2001-04

4. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders.

Authors: Jessica A Hellings; Marilyn Weckbaugh; Elizabeth J Nickel; Sharon E Cain; Jennifer R Zarcone; R Matthew Reese; Sandra Hall; David J Ermer; Luke Y Tsai; Stephen R Schroeder; Edwin H Cook
Journal: J Child Adolesc Psychopharmacol Date: 2005-08 Impact factor: 2.576

Review 5. Intravenous secretin for autism spectrum disorder.

Authors: K W Williams; J J Wray; D M Wheeler
Journal: Cochrane Database Syst Rev Date: 2005-07-20

6. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.

Authors: Eric Hollander; William Chaplin; Latha Soorya; Stacey Wasserman; Sherry Novotny; Jade Rusoff; Nicole Feirsen; Lauren Pepa; Evdokia Anagnostou
Journal: Neuropsychopharmacology Date: 2009-12-09 Impact factor: 7.853

7. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Authors: Randall Owen; Linmarie Sikich; Ronald N Marcus; Patricia Corey-Lisle; George Manos; Robert D McQuade; William H Carson; Robert L Findling
Journal: Pediatrics Date: 2009-12 Impact factor: 7.124

8. A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.

Authors: Kimberly A Stigler; Lael A Desmond; David J Posey; Ryan E Wiegand; Christopher J McDougle
Journal: J Child Adolesc Psychopharmacol Date: 2004 Impact factor: 2.576

9. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Authors: Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra
Journal: JAMA Date: 2009-10-28 Impact factor: 56.272

10. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

Authors: Ronald N Marcus; Randall Owen; Lisa Kamen; George Manos; Robert D McQuade; William H Carson; Michael G Aman
Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-11 Impact factor: 8.829

5 in total

1. Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey.

Authors: Lynn K Koegel; Anna M Krasno; Howard Taras; Robert L Koegel; William Frea
Journal: School Ment Health Date: 2013-02-06